Response to 'Eruptive keratoacanthomas associated with dupilumab therapy'.

Authors :: Patchinsky A
Kalita V
Muller P
Petitpain N
Source :: Skin health and disease [Skin Health Dis] 2023 Mar 02; Vol. 3 (3), pp. e197. Date of Electronic Publication: 2023 Mar 02 (Print Publication: 2023).
Publication Year :: 2023
Abstract: Case of a patient developing multiple rashes of squamous cell carcinoma 6 weeks after the introduction of dupilumab due to atopic eczema.<br />Competing Interests: None to declare.<br /> (© 2022 The Authors. Skin Health and Disease published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.)